Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$62,673,947
+$24,060,737 QoQ
Shares Held
487,735
+51.9% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#276
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $736,177,545 across 12 Drug Manufacturers - General names. MRK ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
4,907,570 | $235,268,905 | |
| 2 | BIIB |
Biogen Inc.
|
788,307 | $170,321,610 | |
| 3 | JNJ |
Johnson & Johnson
|
444,151 | $112,801,029 | |
| 4 | LLY |
ELI LILLY & Co
|
75,669 | $90,759,676 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
487,735 | $62,673,947 | |
| 6 | AZN |
Astrazeneca PLC
|
138,797 | $26,318,686 | |
| 7 | ABBV |
AbbVie Inc.
|
67,742 | $17,046,596 | |
| 8 | AMGN |
Amgen Inc
|
14,074 | $5,096,476 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,673,947 | 487,735 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $38,613,210 | 321,001 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,657,860 | 44,251 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,580,763 | 30,749 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,601,327 | 20,229 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,079,592 | 45,450 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $944,861 | 9,498 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,840,608 | 42,626 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,550,416 | 93,299 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,198,234 | 69,710 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,033,194 | 36,995 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,539,729 | 34,383 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,999,071 | 34,657 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,687,158 | 34,657 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $12,133,492 | 109,360 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,517,389 | 75,678 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $11,325,228 | 124,221 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,135,761 | 26,030 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,879,136 | 24,519 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,046,071 | 27,241 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,118,532 | 27,241 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,100,009 | 27,241 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,228,312 | 27,241 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,259,641 | 27,241 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,426,448 | 57,241 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,481,719 | 97,241 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||